2023 annual financial data
Cue Biopharma 2023 Net margin
Direct answer
Net margin was -924.1%.
Operating income was -52,149,000 USD and net income was -50,733,000 USD.
Operating cash flow was -39,961,000 USD.
Get free Cue Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,490,000 USD
- Operating income
- -52,149,000 USD
- Net income
- -50,733,000 USD
- Operating cash flow
- -39,961,000 USD